|
Delayed
London S.E.
19:35:23 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,853.50 GBX | +0.08% |
|
-3.39% | +1.59% |
| 08-27 | FTSE down as inflation fear offsets Nvidia lift | AN |
| 08-27 | European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading | MT |
Company Valuation: GSK plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,458 | 58,381 | 59,112 | 54,944 | 73,201 | 74,270 | - | - |
| Change | - | -27.44% | 1.25% | -7.05% | 33.23% | 1.46% | - | - |
| Enterprise Value (EV) 1 | 100,296 | 75,578 | 74,152 | 68,039 | 87,654 | 94,108 | 91,330 | 88,335 |
| Change | - | -24.65% | -1.89% | -8.24% | 28.83% | 7.36% | -2.95% | -3.28% |
| P/E | 18.6x | 3.93x | 11.9x | 21.3x | 12.9x | 14x | 11.5x | 10.7x |
| PBR | 5.34x | 5.47x | 4.4x | 4.02x | - | 4.53x | 3.96x | 3.49x |
| PEG | - | 0x | -0.2x | -0.4x | 0x | -2.24x | 0.5x | 1.54x |
| Capitalization / Revenue | 2.36x | 1.99x | 1.95x | 1.75x | 2.24x | 2.19x | 2.09x | 2.03x |
| EV / Revenue | 2.94x | 2.58x | 2.45x | 2.17x | 2.68x | 2.77x | 2.57x | 2.41x |
| EV / EBITDA | 8.85x | 7.23x | 6.37x | 6.36x | 7.77x | 8.21x | 7.45x | 6.96x |
| EV / EBIT | 11.4x | 9.27x | 8.44x | 7.44x | 8.96x | 9.14x | 8.27x | 7.67x |
| EV / FCF | 22.6x | 12.1x | 13.6x | 13x | 13.7x | 17x | 15.8x | 13x |
| FCF Yield | 4.42% | 8.28% | 7.36% | 7.67% | 7.32% | 5.9% | 6.34% | 7.7% |
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.6958 | 0.7495 | 0.7831 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.75% | 4.04% | 4.22% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.323 | 1.616 | 1.728 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 52.6% | 46.4% | 45.3% |
| Net sales 1 | 34,114 | 29,324 | 30,328 | 31,376 | 32,667 | 33,936 | 35,515 | 36,639 |
| EBITDA 1 | 11,330 | 10,449 | 11,635 | 10,693 | 11,278 | 11,464 | 12,256 | 12,693 |
| EBIT 1 | 8,806 | 8,151 | 8,786 | 9,148 | 9,783 | 10,298 | 11,044 | 11,519 |
| Net income 1 | 4,385 | 14,956 | 4,928 | 2,575 | 5,716 | 5,436 | 6,484 | 6,933 |
| Net Debt 1 | 19,838 | 17,197 | 15,040 | 13,095 | 14,453 | 19,838 | 17,060 | 14,065 |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 18.54 | 18.54 | 18.54 |
| Nbr of stocks (in thousands) | 4,006,383 | 4,060,999 | 4,076,145 | 4,080,519 | 4,012,126 | 4,007,011 | - | - |
| Announcement Date | 09/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.01x | 2.77x | 8.21x | 3.75% | 101B | |
| 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 16.86x | 6.16x | 14.90x | 2.51% | 376B | |
| Weighted average by Cap. | 23.97x | 7.90x | 17.50x | 2.01% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GSK Stock
- Valuation GSK plc
Select your edition
All financial news and data tailored to specific country editions
